| |
| |
|
| Insider
Information: |
Benzeno Sharon |
| Relationship: |
Chief Commercial Ofc I... |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
327,415 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,296,563 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
327,415 |
|
|
| Total
Value |
$1,296,563 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adaptive Biotechnologies Corp |
ADPT |
Chief Commercial Ofc I... |
2024-03-05 |
327,415 |
2020-05-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADPT |
Adaptive Biotechnologies ... |
Chief Commercial Ofc Imm Med |
• – – |
2024-03-05 |
4 |
S |
$3.43 |
$100,994 |
D/D |
(29,390) |
327,415 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Commercial Ofc Imm Med |
• – – |
2024-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
132,979 |
356,805 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Commercial Ofc Imm Med |
• – – |
2023-03-06 |
4 |
S |
$8.57 |
$100,689 |
D/D |
(11,749) |
223,826 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Commercial Ofc Imm Med |
• – – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
132,979 |
235,575 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2022-03-07 |
4 |
S |
$12.01 |
$32,067 |
D/D |
(2,670) |
102,596 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2022-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
82,372 |
105,266 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-03-15 |
4 |
AS |
$41.22 |
$56,451 |
D/D |
(1,354) |
22,894 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-03-15 |
4 |
OE |
$31.71 |
$42,935 |
D/D |
1,354 |
24,248 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
22,894 |
22,894 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-03-01 |
4 |
AS |
$57.57 |
$390,143 |
D/D |
(6,771) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-03-01 |
4 |
OE |
$6.55 |
$45,475 |
D/D |
6,771 |
6,771 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-02-19 |
4 |
OE |
$6.27 |
$2,608 |
D/D |
416 |
416 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-02-19 |
4 |
AS |
$61.20 |
$25,459 |
D/D |
(416) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-02-16 |
4 |
OE |
$31.71 |
$515,288 |
D/D |
16,250 |
16,250 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-02-16 |
4 |
AS |
$63.42 |
$1,050,381 |
D/D |
(16,250) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-02-01 |
4 |
AS |
$55.61 |
$376,720 |
D/D |
(6,770) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-02-01 |
4 |
OE |
$6.55 |
$45,468 |
D/D |
6,770 |
6,770 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-01-19 |
4 |
AS |
$69.00 |
$28,773 |
D/D |
(417) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-01-19 |
4 |
OE |
$6.27 |
$2,615 |
D/D |
417 |
417 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-01-04 |
4 |
OE |
$6.55 |
$45,475 |
D/D |
6,771 |
6,771 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2021-01-04 |
4 |
AS |
$56.12 |
$388,583 |
D/D |
(6,771) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-12-21 |
4 |
AS |
$59.14 |
$24,661 |
D/D |
(417) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-12-21 |
4 |
OE |
$6.27 |
$2,615 |
D/D |
417 |
417 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-12-01 |
4 |
AS |
$48.20 |
$330,856 |
D/D |
(6,770) |
0 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Business Development Off |
• – – |
2020-12-01 |
4 |
OE |
$6.55 |
$45,468 |
D/D |
6,770 |
6,770 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
